{"organizations": [], "uuid": "e882cce69e14a1ec0a357eaf5ad3de1277a9fd77", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180206.html", "section_title": "Archive News &amp; Video for Tuesday, 06 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-iradimed-corporation-q4-eps-002/brief-iradimed-corporation-q4-eps-0-02-idUSASB0C460", "country": "US", "domain_rank": 408, "title": "BRIEF-Iradimed Corporation Q4 EPS $0.02", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.983, "site_type": "news", "published": "2018-02-06T20:34:00.000+02:00", "replies_count": 0, "uuid": "e882cce69e14a1ec0a357eaf5ad3de1277a9fd77"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-iradimed-corporation-q4-eps-002/brief-iradimed-corporation-q4-eps-0-02-idUSASB0C460", "ord_in_thread": 0, "title": "BRIEF-Iradimed Corporation Q4 EPS $0.02", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "brief-iradimed corporation", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "iradimed corp", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 6 (Reuters) - Iradimed Corp:\n* IRADIMED CORPORATION ANNOUNCES FOURTH QUARTER 2017 FINANCIAL RESULTS\n* Q4 NON-GAAP EARNINGS PER SHARE $0.10 * Q4 GAAP EARNINGS PER SHARE $0.02 * Q4 REVENUE $6.7 MILLION VERSUS $6.0 MILLION * SEES FY 2018 NON-GAAP EARNINGS PER SHARE $0.33 TO $0.38 * SEES Q1 2018 NON-GAAP EARNINGS PER SHARE $0.06 TO $0.07 * SEES FY 2018 GAAP EARNINGS PER SHARE $0.22 TO $0.27 * SEES Q1 2018 GAAP EARNINGS PER SHARE $0.04 TO $0.05 * SEES FY 2018 REVENUE $29.3 MILLION TO $30 MILLION * SEES Q1 2018 REVENUE $6.8 MILLION TO $6.9 MILLION * ‍NET INCOME FOR Q4 AND FULL YEAR 2017 WAS NEGATIVELY IMPACTED AS A RESULT OF TAX CUTS AND JOBS ACT​\n* ‍REDUCTION IN U.S. FEDERAL CORPORATE TAX RATE EXPECTED TO POSITIVELY IMPACT IRADIMED‘S FUTURE EARNINGS​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-06T20:34:00.000+02:00", "crawled": "2018-02-07T22:23:06.015+02:00", "highlightTitle": ""}